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PERSPECTIVE
Craniofacial Ciliopathies and the
Interpretation of Hedgehog Signal
Transduction
Karen J. Liu*
Craniofacial Development & Stem Cell Biology, King’s College London, Guy’s Hospital, London, United
Kingdom
* karen.liu@kcl.ac.uk
An emerging body of literature has shown that cilia-dependent Hedgehog (HH) signaling is
crucial to the patterning of the face. Ciliopathic mutations are frequently associated with cra-
niofacial anomalies, and while the links are clear, the observed phenotypes can vary widely,
leading to confusion about how these mutations affect processing of HH effectors. In Novem-
ber 2016’s issue of PLOS Genetics, Chang et al. uncover an important role for HH-dependent
transcriptional repression during facial development.
Cilia and Developmental Roles for HH Signaling
Cilia are tiny, hair-like projections found on the surface of eukaryotic cells. These projec-
tions can be motile, aiding in the movement of cells and surrounding liquids. There are also
immotile cilia, which are notable in vertebrates for the interpretation of many extracellular
signals [1]. Cilia are complex organelles, requiring a suite of proteins involved in cellular
functions as disparate as protein synthesis, microtubule organization, vesicular trafficking,
and intraflagellar transport. Therefore, it is no surprise that numerous studies in animal
models have demonstrated that cilia proteins are crucial for the patterning of developing
organs. Because the majority of cells have cilia, affected organ systems are diverse, and
altered function could potentially lead to a wide range of human diseases. Recent advances
in genetic analysis confirm this theory, as multiple mutations affecting cilium structure and
function have been implicated in congenital anomalies. The craniofacial complex is one of
the systems most commonly affected by cilia dysfunction.
Of the many external cues, HH signal transduction has emerged as a key molecular path-
way reliant on functional cilia [2,3]. However, despite the many ciliopathic animal models
that now exist, a great deal of confusion arises when studying the consequences of cilia muta-
tions on HH. In some studies, mutations mimic a loss of HH signaling, while in other con-
texts, HH signaling appears to increase. This has been particularly evident in craniofacial
structures, where loss of cilia can lead to both narrowing of the head with failure of separa-
tion of the forebrain hemispheres (holoprosencephaly, associated with loss of HH) and wid-
ening of the mid-face (associated with gain of HH) [4,5]. Altogether, this suggests that the
phenotypic interpretation of HH signaling changes is more complicated than a simple on/off
mechanism. In this issue, Chang et al. mutate the intraflagellar transport proteins Ift88 and
Kif3a in the mouse neural crest, comparing the phenotypes to those associated with func-
tional mutations in the HH effectors Gli2 and Gli3 [6]. In doing so, they clarify the molecular
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basis for facial widening in ciliopathies and uncover a novel in vivo requirement for GLI-
mediated transcriptional repression.
Cilia and the Balance of GLI Functions
In vertebrates, the intracellular components of the HH pathway are sequestered in the cilium
(Fig 1) [1]. Upon binding of the HH ligand to its receptor Patched (PTC), the transmembrane
receptor Smoothened (SMO) translocates to the cilium, where it triggers the processing of the
downstream transcriptional effectors GLI2 and GLI3 (Fig 1B). (A third GLI, GLI1, lacks a
repressor domain and appears dispensable for embryonic development.) In the cilium, GLI2
and GLI3 associate with Suppressor of Fused (SUFU), and a SMO-triggered release of SUFU is
necessary for subsequent GLI activator (GLIA) function. Both GLI2 and GLI3 can be modified
to a long activator form or proteolytically cleaved to a truncated repressor form (GLIR). In
vitro, both GLI2R and GLI3R are able to inhibit HH target genes; however, to date, the major-
ity of evidence has suggested that GLI3 is the primary repressor in vivo, while GLI2 mediates
the bulk of HH activation. In vivo, the difficulty in understanding HH signaling lies in the
unique and overlapping functions of the GLI proteins. Until this report, an in vivo role for pro-
teolytic processing of GLI2 had been elusive, particularly as previous reports demonstrated
that the constitutively active Gli1 could substitute for Gli2 in a genetic knock-in [7].
Our current understanding of GLI processing in the cilium suggested that recruitment of
SMO to the cilium leads to an increase in the ratio of GLI activator to GLI repressor (GLIA:
GLIR) [8,9]. Therefore, tissue-specific interpretation of the GLIA:GLIR ratio could be due to
different combinations of binding partners or varying accessibility of target promoters. Fur-
thermore, we could postulate a dedicated set of GLIR targets that are entirely immune to GLIA
binding and vice versa. Crucially, different tissues appear to use different ratios of GLIA:GLIR.
Together, this suggests a complex interplay of three classes of GLI target genes. For example,
HH signaling in dorsal–ventral patterning of the neural tube appears to balance GLI3 repres-
sion in the dorsal domain with GLI2 activation in the ventral domain [10]. In contrast, loss of
Fig 1. Hedgehog (HH) signaling in the cilium. A) In the off state, the HH receptor Patched 1 (PTC1) represses Smoothened (SMO), keeping it out of the
cilium. The HH effectors GLI2 and GLI3 localize to the cilium with the help of transport proteins KIF3A and IFT88. Here, they can be proteolytically cleaved
to short repressor forms. Full-length GLIs are targeted for degradation. B) In the presence of HH ligand, SMO translocates to the cilium, where it
antagonizes the SUFU–GLI association, leading to production and nuclear translocation of GLI activators. C) In ciliopathic Kif3a and Ift88 mutants, HH
signaling is unable to disrupt the SUFU–GLI association. This shifts the nuclear ratio of GLIA:GLIR, leading to an increase in full-length GLI (GLIFL) and a
reduction in levels of the shorter GLIR.
doi:10.1371/journal.pgen.1006460.g001
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GLI3R function in rhombomere 1 in the hindbrain is sufficient to de-repress expression of
fibroblast growth factor-8 (Fgf8) [11]. Similarly, in the limbs, loss of GLI3R leads to severe poly-
dactyly; here, the role of the ligand appears to be to limit the repressor, as loss of sonic hedgehog
(Shh) skews the ratio toward GLI3R, resulting in a single digit forming [12,13].
In this paper, Chang et al. demonstrate that disruption of cilia function leads to an increase
in the amount of full-length GLI2 and GLI3 in the nucleus, thus shifting the ratio of GLIA:
GLIR toward the activator form [6]. This was partially rectified by increasing the amounts of
GLI3R. However, complete genetic loss of all Gli3 in the neural crest did not elicit the same
phenotype, suggesting that GLI3 repressor did not encompass the full extent of the HH read-
out. Indeed, the midfacial phenotype was only seen when both Gli2 and Gli3 were eliminated,
demonstrating that both GLIs contributed to the phenotype and raising the possibility of a
compensatory role for GLI2R that is only uncovered in the absence of GLI3R. By systemati-
cally comparing a suite of ciliopathy mutations with different functional mutants of Gli2 and
Gli3, Chang et al. provide novel structure–function associations with distinct pathologies.
This paper also highlights the importance of tissue specificity in the interpretation of devel-
opmental phenotypes, especially with cues such as HH that are used reiteratively. By limiting
mutations to the neural crest tissues, the authors were able to determine that a key function for
HH in the neural crest mesenchyme is controlling the levels of transcriptional repression.
Future experiments should examine more lineage-restricted tissues in the face as well as tem-
poral requirements.
Of course, a number of open questions remain: Is the continued association with SUFU
truly preventing GLI activator function? Is there a role for the cilium in GLI interactions with
other regulators or post-translational modifiers? We also need a more accurate way to follow
changing GLIA:GLIR ratios in vivo and to compare these to GLI-dependent responses. Finally,
we must note that cilia are likely to coordinate multiple other signaling pathways; in the long
term, how these pathways intersect will be crucial to our understanding of cilia and human
disease.
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